Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digital PCR for Deep Sensitivity BCR::ABL1 Mutation Screening in CML

NCT07158294 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT07158294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07158294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digital PCR for Deep Sensitivity BCR::ABL1 Mutation Screening in CML
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
April 1, 2029
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml)